Literature DB >> 11250967

Electromechanical interrelations during dobutamine stress in normal subjects and patients with coronary artery disease: comparison of changes in activation and inotropic state.

A M Duncan1, C A O'Sullivan, D G Gibson, M Y Henein.   

Abstract

OBJECTIVE: To identify the effects of altered ventricular activation during dobutamine stress on left ventricular function in normal subjects and in patients with coronary artery disease, and to distinguish these from an inotropic response.
DESIGN: Prospective analysis of 12 lead ECG and echocardiogram at rest and at peak stress.
SETTING: Tertiary referral centre for cardiac disease equipped with non-invasive facilities for pharmacological stress testing.
METHODS: 22 patients with coronary artery disease were compared with 17 age matched controls. Left ventricular ejection and filling patterns were assessed using Doppler echocardiography. Activation effects were correlated with relative left ventricular ejection and filling times, and the Z ratio ([left ventricular ejection + filling times]/RR interval). Inotropic response was measured from peak aortic acceleration.
RESULTS: In controls, QRS shortened (by 4 ms, p < 0.001), and total ejection and filling periods lengthened (by 2 s/min, p < 0.01 and 5 s/min, p < 0.001, respectively). The Z ratio thus increased and correlated with QRS shortening (r(2) = 0.69). Peak aortic acceleration (PAA) increased by 135%, p < 0.001. In patients, QRS lengthened at peak stress (by 9 ms, p < 0.001). Total ejection and filling times did not change, but Z ratio fell, correlating with QRS prolongation (r(2) = 0.65). Nevertheless, PAA increased by 63%, p < 0.001.
CONCLUSIONS: Relative ejection and filling times reflect ventricular activation at rest and during stress independent of changes in inotropic state. By contrast, peak aortic acceleration reflects the positive inotropic effect of dobutamine on the myocardium, regardless of changes in activation.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11250967      PMCID: PMC1729674          DOI: 10.1136/heart.85.4.411

Source DB:  PubMed          Journal:  Heart        ISSN: 1355-6037            Impact factor:   5.994


  12 in total

1.  How high can a correlation coefficient be? Effects of limited reproducibility of common cardiological measures.

Authors:  D P Francis; A J Coats; D G Gibson
Journal:  Int J Cardiol       Date:  1999-05-15       Impact factor: 4.164

2.  Different effects of abnormal activation and myocardial disease on left ventricular ejection and filling times.

Authors:  Q Zhou; M Henein; A Coats; D Gibson
Journal:  Heart       Date:  2000-09       Impact factor: 5.994

3.  New non-invasive index for combined systolic and diastolic ventricular function.

Authors:  C Tei
Journal:  J Cardiol       Date:  1995-08       Impact factor: 3.159

4.  Serial evaluation of left ventricular function in congestive heart failure by measurement of peak aortic blood acceleration.

Authors:  H N Sabbah; M Gheorghiade; S T Smith; D M Frank; P D Stein
Journal:  Am J Cardiol       Date:  1988-02-01       Impact factor: 2.778

5.  Maximum acceleration of blood from the left ventricle in patients with ischaemic heart disease.

Authors:  E D Bennett; W Else; G A Miller; G C Sutton; H C Miller; M I Noble
Journal:  Clin Sci Mol Med       Date:  1974-01

6.  Measurement of instantaneous left ventricular dimension and filling rate in man, using echocardiography.

Authors:  D G Gibson; D Brown
Journal:  Br Heart J       Date:  1973-11

7.  Echocardiographic detection of coronary artery disease during dobutamine infusion.

Authors:  S G Sawada; D S Segar; T Ryan; S E Brown; A M Dohan; R Williams; N S Fineberg; W F Armstrong; H Feigenbaum
Journal:  Circulation       Date:  1991-05       Impact factor: 29.690

8.  Blood pressure and flow in the ascending aorta of conscious dogs.

Authors:  M I Noble; I T Gabe; D Trenchard; A Guz
Journal:  Cardiovasc Res       Date:  1967-01       Impact factor: 10.787

9.  The beta-adrenoceptor subtype(s) mediating adrenaline- and dobutamine-induced blood pressure and heart rate changes in healthy volunteers.

Authors:  A Daul; U Hermes; R F Schäfers; R Wenzel; C von Birgelen; O E Brodde
Journal:  Int J Clin Pharmacol Ther       Date:  1995-03       Impact factor: 1.366

10.  Abnormal ventricular activation and repolarisation during dobutamine stress echocardiography in coronary artery disease.

Authors:  C A O'Sullivan; M Y Henein; R Sutton; A J Coats; G C Sutton; D G Gibson
Journal:  Heart       Date:  1998-05       Impact factor: 5.994

View more
  4 in total

1.  Long axis electromechanics during dobutamine stress in patients with coronary artery disease and left ventricular dysfunction.

Authors:  A M Duncan; C A O'Sullivan; G S Carr-White; D G Gibson; M Y Henein
Journal:  Heart       Date:  2001-10       Impact factor: 5.994

2.  Changes in the Doppler myocardial performance index during dobutamine echocardiography: association with neurohormonal activation and prognosis after acute myocardial infarction.

Authors:  B Nørager; M Husic; J E Møller; A Bo Hansen; P A Pellikka; K Egstrup
Journal:  Heart       Date:  2005-12-30       Impact factor: 5.994

Review 3.  Expert consensus document: Echocardiography and lung ultrasonography for the assessment and management of acute heart failure.

Authors:  Susanna Price; Elke Platz; Louise Cullen; Guido Tavazzi; Michael Christ; Martin R Cowie; Alan S Maisel; Josep Masip; Oscar Miro; John J McMurray; W Frank Peacock; F Javier Martin-Sanchez; Salvatore Di Somma; Hector Bueno; Uwe Zeymer; Christian Mueller
Journal:  Nat Rev Cardiol       Date:  2017-04-27       Impact factor: 32.419

4.  Intensive care unit management of percutaneous mechanical circulatory supported patients: the role of imaging.

Authors:  Andrea Montisci; Letizia F Bertoldi; Susanna Price; Christian Hassager; Jacob Møller; Federico Pappalardo
Journal:  Eur Heart J Suppl       Date:  2021-03-27       Impact factor: 1.803

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.